Manhattan, NY JLL completed a new transaction for Quentis Therapeutics at 1361 Amsterdam Ave., also known as the Mink Building, in the West Harlem neighborhood with Janus Property Co. The cancer immunotherapy startup firm signed a lease for 10,000 s/f of laboratory and office space.
The tenant was represented by John Cahill, senior vice president, with JLL’s Life Sciences practice group, along with Evan Margolin, vice chairman, with Savills Studley. Building owner Janus Property was represented in-house.
“Quentis will be able to expand its growing operations thanks to funds from the NYEDC,” said Cahill. “The move allows the life sciences firm to consolidate its research facilities into one state-of-the-art location in West Harlem. The location was ideal for Quentis as its new home is located near Columbia University’s Manhattanville campus and the CUNY Advanced Science Research Center.”
Quentis Therapeutics signed a lease for 10,000 square feet of research and development/ laboratory/office space and will occupy part of the fifth floor at 1361 Amsterdam Ave. The cancer immunotherapy startup is relocating to the building from the Alexandria Center for Life Sciences, 430 East 29th St., and from space it occupies at JLABS @ NYC, located at 101 Avenue of the Americas.
The biotech firm is expanding in West Harlem in part thanks to a $1 million grant from the New York Economic Development Corp. The money comes from a $10 million LifeSci NYC Expansion Space Fund established by the NYEDC to help life sciences companies expand in the city.
The five-story 1361 Amsterdam Ave., also known as the Mink Building, was constructed in 1911. The building was part of the former Yuengling Brewery complex that became a fur storage warehouse in the 1940s. The property was converted to office space after being acquired by Janus Property in 1997. The new owner has completed extensive renovations at 1361 Amsterdam Ave., with the building now featuring a new facade, new elevator, new lobby, and new windows.
Sign up is quick, easy, & FREE.